Another study by Kenney et al. (2018) examined plasma-derived exosomal concentrations of amyloid-beta (A), tau protein, and phosphorylated tau (p-tau) in persons with a history of combat-related mTBI with persistent cognitive impairment symptoms. The gene discussed is MAPT; the disease is Cognitive impairment.